Kairos Pharma Ltd (KAPA) Stock Price, Quote & News

Company Profile

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The company develops KROS 101, an orally available glucocorticoid-induced tumor necrosis factor receptor (GITR) ligand small-molecule antagonist to deplete regulatory T cells (Tregs) and activate effector T cells to augment the antitumor immune respons...

Industry: Biotechnology

Sector: Healthcare

Phone: 310 948 2356

Website: kairospharma.com

Address:

2355 Westwood Boulevard, Suite 139, Los Angeles, United States

Sloan88 Jan. 20 at 5:32 PM

$KAPA who’s ready for 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

Xtracked Jan. 20 at 2:05 AM

$KAPA Anybody's estimate? Where is everyone on this board?

2 · Reply

Xtracked Jan. 19 at 1:50 AM

$KAPA No market tomorrow. Any guesses on SP day of partnership news? I'm guessing $4 minimum. Possible $6...IMO

0 · Reply

Sloan88 Jan. 16 at 8:08 PM

$KAPA Club 150 anyone else going there with me🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️💰💰💰💰💰🔥🔥🔥🔥🔥🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

Ueberschlaefer Jan. 16 at 4:03 AM

$KAPA four employees... lol. another biotech lifestyle company for grifters.

3 · Reply

Sloan88 Jan. 14 at 6:21 PM

$KAPA it’s a start🤷🏻‍♂️🤷🏻‍♂️

1 · Reply

Sloan88 Jan. 14 at 9:26 AM

$KAPA Just so everyone knows the 950,000 insider buys are RSU grants not buys vesting in 12 months maybe we should start reading the filings not following some self proclaimed trading god🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️

3 · Reply

StrawberryRips Jan. 14 at 6:39 AM

$KAPA buys were all above $1

1 · Reply

StrawberryRips Jan. 14 at 6:37 AM

$KAPA insider buys always a good sign. Insider employees are less likely to dilute…

0 · Reply

GreenBeam33 Jan. 13 at 7:25 PM

$KAPA about 800k shares have been bought this past month by insiders

1 · Reply

Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference

Dec 17, 2025, 8:15 AM EST - 4 weeks ago

Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer

Nov 4, 2025, 8:00 AM EST - 2 months ago

Kairos Pharma Provides Shareholder Update

Oct 20, 2025, 8:00 AM EDT - 3 months ago

Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting

Oct 7, 2025, 8:00 AM EDT - 3 months ago

Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025

Sep 18, 2025, 8:00 AM EDT - 4 months ago

Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year

Sep 11, 2025, 8:00 AM EDT - 4 months ago

Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer

Sep 3, 2025, 8:15 AM EDT - 4 months ago

Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025

Sep 2, 2025, 4:05 PM EDT - 5 months ago

Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Jul 28, 2025, 12:28 PM EDT - 6 months ago

CEO.CA's Inside the Boardroom: Kairos Pharma CEO on Phase 2 Safety Data, 165% Stock Move & September Efficacy Timeline

Jul 16, 2025, 8:30 AM EDT - 6 months ago

Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025

Jul 15, 2025, 2:08 PM EDT - 6 months ago

Why Is Kairos Pharma Stock Surging On Tuesday?

Jul 15, 2025, 8:00 AM EDT - 6 months ago

Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer

Jun 3, 2025, 8:15 AM EDT - 8 months ago

Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

May 6, 2025, 8:00 AM EDT - 9 months ago

Kairos Pharma, Ltd. Announces Participation in the D.

Apr 28, 2025, 8:00 AM EDT - 9 months ago

Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

Apr 24, 2025, 8:00 AM EDT - 9 months ago

Kairos Pharma Ltd. Provides Letter to Stockholders

Apr 17, 2025, 8:00 AM EDT - 9 months ago

Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer

Mar 31, 2025, 7:00 AM EDT - 10 months ago

Kairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate Cancer

Mar 27, 2025, 4:05 PM EDT - 10 months ago

Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events

Mar 20, 2025, 7:30 AM EDT - 10 months ago

Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer

Feb 26, 2025, 7:00 AM EST - 11 months ago

Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds' Potential as Therapeutics for Melanoma and Glioblastoma

Feb 18, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Announces New Department of Defense Funding for Research of ENV205

Feb 11, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Adds Huntsman Cancer Institute for Phase 2 ENV105 Clinical Trial

Feb 6, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound's Potential as a Therapeutic for Melanoma and Glioblastoma

Jan 28, 2025, 8:15 AM EST - 1 year ago

Kairos Pharma to Present Short Talk on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference February 5, 2024

Jan 21, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Provides Business Update and Outlook into 2025

Jan 7, 2025, 8:15 AM EST - 1 year ago

Kairos Pharma to Present at the Lytham Partners Investor Healthcare Summit

Dec 26, 2024, 7:51 AM EST - 1 year ago

Kairos Pharma: Potential To Remove Resistance With Established Drugs

Dec 16, 2024, 12:15 PM EST - 1 year ago

Kairos Pharma to Participate in The Microcap Conference in January 2025

Dec 3, 2024, 8:30 AM EST - 1 year ago

Kairos Pharma Adds City of Hope Cancer Center for Phase 2 ENV105 Clinical Trial

Nov 26, 2024, 8:30 AM EST - 1 year ago

IBN Initiates Coverage of Kairos Pharma Ltd.

Oct 22, 2024, 9:00 AM EDT - 1 year ago

Kairos Pharma to Present at the LD Micro Main Event XVII

Oct 9, 2024, 4:30 PM EDT - 1 year ago

Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Sep 24, 2024, 4:20 PM EDT - 1 year ago

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

Sep 21, 2024, 2:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost

BIOA BKV FBGL GLE GRDN LGCY PRB

Sep 17, 2024, 4:29 PM EDT - 1 year ago

Kairos Pharma Closing of $6.2 Million Initial Public Offering

Sep 16, 2024, 10:49 AM EDT - 1 year ago

Kairos Pharma Prices $6.2 Million Initial Public Offering

Feb 14, 2024, 6:16 PM EST - 2 years ago

Kairos Pharma to sell 1.55 million shares in IPO at $4 each

Oct 3, 2023, 3:33 PM EDT - 2 years ago

Kairos Pharma Files For U.S. IPO

Sloan88 Jan. 20 at 5:32 PM

$KAPA who’s ready for 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

Xtracked Jan. 20 at 2:05 AM

$KAPA Anybody's estimate? Where is everyone on this board?

2 · Reply

Xtracked Jan. 19 at 1:50 AM

$KAPA No market tomorrow. Any guesses on SP day of partnership news? I'm guessing $4 minimum. Possible $6...IMO

0 · Reply

Sloan88 Jan. 16 at 8:08 PM

$KAPA Club 150 anyone else going there with me🤷🏻‍♂️🤷🏻‍♂️🤷🏻‍♂️💰💰💰💰💰🔥🔥🔥🔥🔥🚀🚀🚀🚀🚀🚀🚀🚀

1 · Reply

Ueberschlaefer Jan. 16 at 4:03 AM

$KAPA four employees... lol. another biotech lifestyle company for grifters.

3 · Reply

Sloan88 Jan. 14 at 6:21 PM

$KAPA it’s a start🤷🏻‍♂️🤷🏻‍♂️

1 · Reply

Sloan88 Jan. 14 at 9:26 AM

3 · Reply

StrawberryRips Jan. 14 at 6:39 AM

$KAPA buys were all above $1

1 · Reply

StrawberryRips Jan. 14 at 6:37 AM

$KAPA insider buys always a good sign. Insider employees are less likely to dilute…

0 · Reply

GreenBeam33 Jan. 13 at 7:25 PM

$KAPA about 800k shares have been bought this past month by insiders

1 · Reply

GreenBeam33 Jan. 13 at 7:10 PM

$KAPA John yu better not screw over your investors

0 · Reply

Artadas Jan. 13 at 5:07 PM

$KAPA so its 1.4$ warrants and lots of shares to dilute, nothing bulish here, if they are doing that, they got no buy offers or any good news in upcoming future and they will need cash to sustain. looking for 0.6$ to re enter

1 · Reply

ezcheezie Jan. 13 at 11:20 AM

$KAPA Well, hopefully they drop some breaking news to pair with that offering.

1 · Reply

TrdrBuckNKy Jan. 13 at 12:10 AM

$KAPA I don't think you're being negative. All your points are considerably valid. These guys might have a great product, however, something doesn't feel right here.

0 · Reply

Xtracked Jan. 12 at 2:25 PM

$KAPA WITF are they waiting for? Silent....... Let's go:)

2 · Reply

ezcheezie Jan. 10 at 12:24 AM

$KAPA lots of new investor purchases, all at the same price point. It's always good to see vanguard throwing their hat into the ring too. Yesterday was a nice taste I think(hope).

0 · Reply

Xtracked Jan. 9 at 11:42 PM

$KAPA I agree completely:) Look at last yrs action, and something leaked yesterday IMO. Thus the large purchases in the morning. If big , news Monday:)

0 · Reply

TB85 Jan. 9 at 9:38 PM

$KAPA If no updates/news before end of the month, im starting to get a little more pessimistic on this. Dont like the silence! But at the same time, how many fail in a phase 1 study, not many. And a pm about partnership with BP, is highly speculative, and would be a major jackpot if that happens. What do you guys think, am I just being negative here?

1 · Reply

Artadas Jan. 9 at 9:11 PM

$KAPA looks like it want to hit my buy zone again:)

0 · Reply

ezcheezie Jan. 9 at 2:28 PM

$KAPA I wouldn't expect a ton of action today. Hold your position, next week will be big.

0 · Reply

Sloan88 Jan. 9 at 1:37 PM

$KAPA once we break the big ask @ .97 then we can start the fun💰💰💰💰💰

0 · Reply

Miikke Jan. 8 at 7:12 PM

$KAPA why is it stuck at 0.9700 like it frozen for over an hour can anyone tell me please did it halt is it news

2 · Reply

Market Cap	18.17M
Revenue (ttm)	0.00
Net Income (ttm)	-2.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	66,159
Avg Vol	163,102
Day's Range	N/A - N/A
Shares Out	20.82M
Stochastic %K	36%
Beta	2.28
Analysts	Strong Sell
Price Target	$8.33